Open Access
| Issue |
Med Sci (Paris)
Volume 42, Number 5, Mai 2026
|
|
|---|---|---|
| Page(s) | 419 - 420 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2026085 | |
| Published online | 29 mai 2026 | |
- Libby P, Soehnlein O. Immunity 2025 ; 58 : 2383-401. [Google Scholar]
- Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017 ; 377 : 1119-31. [CrossRef] [PubMed] [Google Scholar]
- Jolly SS, d’Entremont MA, Lee SF, et al. Colchicine in acute myocardial infarction. N Engl J Med 2025 ; 392 : 633-42. [Google Scholar]
- Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999 ; 85 : e17-24. [Google Scholar]
- Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of transforming growth factor-b signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001 ; 89 : 930-4. [Google Scholar]
- Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 ; 12 : 178-80. [Google Scholar]
- Mallat Z, Gojova A, Brun V, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 ; 108 : 1232-7. [Google Scholar]
- Weirather J, Hofmann UD, Beyersdorf N, et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res 2014 ; 115 : 55-67. [Google Scholar]
- Ait-Oufella H, Wang Y, Herbin O, et al. Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice. Arterioscler Thromb Vasc Biol 2013 ; 33 : 2374-9. [Google Scholar]
- Zouggari Y, Ait-Oufella H, Waeckel L, et al. Regulatory T cells modulate postischemic neovascularization. Circulation 2009 ; 120 : 1415-25. [Google Scholar]
- Herbin O, Ait-Oufella H, Yu W, et al. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012 ; 32 : 605-12. [Google Scholar]
- Saadoun D, Rosenzwajg M, Joly F, et al. Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 2011 ; 365 : 2067-77. [Google Scholar]
- Zhao TX, Sriranjan RS, Tuong ZK, et al. Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease. N Engl J Med Evid 2022 ; 1 : EVIDoa2100009. [Google Scholar]
- Sriranjan-Rothwell RS, Zhao TX, Hoole SP, et al. Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial. Nat Med 2026 ; 32 : 624-32. [Google Scholar]
- Ridker PM, MacFadyen JG, Thuren T, et al. CANTOS Trial Group. Effect of interleukin-1b inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 2017 ; 390 : 1833-42. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.